HIFs and tumors -: causes and consequences

被引:160
作者
Höpfl, G [1 ]
Ogunshola, O [1 ]
Gassmann, M [1 ]
机构
[1] Univ Zurich, Inst Vet Physiol, CH-8057 Zurich, Switzerland
关键词
hypoxia; cancer; oxygen-sensing; oncogenes; vasculature;
D O I
10.1152/ajpregu.00538.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
For most organisms oxygen is essential for life. When oxygen levels drop below those required to maintain the minimum physiological oxygen requirement of an organism or tissue it is termed hypoxia. To counteract possible deleterious effects of such a state, an immediate molecular response is initiated causing adaptation responses aimed at cell survival. This response is mediated by the hypoxia-inducible factor-1 (HIF-1), which is a heterodimer consisting of an alpha- and a beta-subunit. HIF-1alpha protein is stabilized under hypoxic conditions and therefore confers selectivity to this response. Hypoxia is characteristic of tumors, mainly because of impaired blood supply resulting from abnormal growth. Over the past few years enormous progress has been made in the attempt to understand how the activation of the physiological response to hypoxia influences neoplastic growth. In this review some aspects of HIF-1 pathway activation in tumors and the consequences for pathophysiology and treatment of neoplasia are discussed.
引用
收藏
页码:R608 / R623
页数:16
相关论文
共 272 条
  • [1] Aebersold DM, 2001, CANCER RES, V61, P2911
  • [2] Agani F, 1997, CANCER RES, V57, P4474
  • [3] Akakura N, 2001, CANCER RES, V61, P6548
  • [4] c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription
    Alfranca, A
    Gutiérrez, MD
    Vara, A
    Aragonés, J
    Vidal, F
    Landázuri, MO
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) : 12 - 22
  • [5] Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension
    Alvarez-Tejado, M
    Alfranca, A
    Aragonés, J
    Vara, A
    Landázuri, MO
    del Peso, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 13508 - 13517
  • [6] Stabilization of wild-type p53 by hypoxia-inducible factor 1α
    An, WG
    Kanekal, M
    Simon, MC
    Maltepe, E
    Blagosklonny, MV
    Neckers, LM
    [J]. NATURE, 1998, 392 (6674) : 405 - 408
  • [7] Human hormone-refractory prostate cancers can harbor mutations in the 02-dependent degradation domain of hypoxia inducible factor-1α (HIF-1α)
    Anastasiadis, AG
    Ghafar, MA
    Salomon, L
    Vacherot, F
    Benedit, P
    Chen, MW
    Shabsigh, A
    Burchardt, M
    Chopin, DK
    Shabsigh, R
    Buttyan, R
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (07) : 358 - 362
  • [8] An essential role for p300/CBP in the cellular response to hypoxia
    Arany, Z
    Huang, LE
    Eckner, R
    Bhattacharya, S
    Jiang, C
    Goldberg, MA
    Bunn, HF
    Livingston, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) : 12969 - 12973
  • [9] Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription
    Arsham, AM
    Plas, DR
    Thompson, CB
    Simon, MC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) : 15162 - 15170
  • [10] Recruitment of p300/CBP in p53-dependent signal pathways
    Avantaggiati, ML
    Ogryzko, V
    Gardner, K
    Giordano, A
    Levine, AS
    Kelly, K
    [J]. CELL, 1997, 89 (07) : 1175 - 1184